<?xml version='1.0' encoding='utf-8'?>
<document id="29302757"><sentence text="Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1)."><entity charOffset="0-9" id="DDI-PubMed.29302757.s1.e0" text="Indinavir" /><entity charOffset="41-51" id="DDI-PubMed.29302757.s1.e1" text="Lamivudine" /><pair ddi="false" e1="DDI-PubMed.29302757.s1.e0" e2="DDI-PubMed.29302757.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s1.e0" e2="DDI-PubMed.29302757.s1.e1" /></sentence><sentence text="Lamivudine, a characterized substrate for human multidrug and toxin extrusion protein 1 (hMATE1) in vitro, was commonly used with indinavir as a therapy against human immunodeficiency virus (HIV)"><entity charOffset="0-10" id="DDI-PubMed.29302757.s2.e0" text="Lamivudine" /><entity charOffset="130-139" id="DDI-PubMed.29302757.s2.e1" text="indinavir" /><pair ddi="false" e1="DDI-PubMed.29302757.s2.e0" e2="DDI-PubMed.29302757.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s2.e0" e2="DDI-PubMed.29302757.s2.e1" /></sentence><sentence text=" We aimed to investigate whether mouse MATE1 is involved in the disposition of lamivudine in vivo, and whether there is any transporter-mediated interaction between indinavir and lamivudine"><entity charOffset="79-89" id="DDI-PubMed.29302757.s3.e0" text="lamivudine" /><entity charOffset="165-174" id="DDI-PubMed.29302757.s3.e1" text="indinavir" /><entity charOffset="179-189" id="DDI-PubMed.29302757.s3.e2" text="lamivudine" /><pair ddi="false" e1="DDI-PubMed.29302757.s3.e0" e2="DDI-PubMed.29302757.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s3.e0" e2="DDI-PubMed.29302757.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29302757.s3.e0" e2="DDI-PubMed.29302757.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29302757.s3.e1" e2="DDI-PubMed.29302757.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29302757.s3.e1" e2="DDI-PubMed.29302757.s3.e2" /></sentence><sentence text="" /><sentence text="The role of MATE1 in the disposition of lamivudine was determined using Mate1 wild type (+/+) and knockout (-/-) mice"><entity charOffset="40-50" id="DDI-PubMed.29302757.s5.e0" text="lamivudine" /></sentence><sentence text=" The inhibitory potencies of indinavir on lamivudine uptake mediated by OCT2 and MATE1 were determined in human embryonic kidney 293 (HEK 293) cells stably expressing these transporters"><entity charOffset="29-38" id="DDI-PubMed.29302757.s6.e0" text="indinavir" /><entity charOffset="42-52" id="DDI-PubMed.29302757.s6.e1" text="lamivudine" /><pair ddi="false" e1="DDI-PubMed.29302757.s6.e0" e2="DDI-PubMed.29302757.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s6.e0" e2="DDI-PubMed.29302757.s6.e1" /></sentence><sentence text=" The role of MATE1 in the interaction between indinavir and lamivudine in vivo was determined using Mate1 (+/+) and Mate1 (-/-) mice"><entity charOffset="46-55" id="DDI-PubMed.29302757.s7.e0" text="indinavir" /><entity charOffset="60-70" id="DDI-PubMed.29302757.s7.e1" text="lamivudine" /><pair ddi="false" e1="DDI-PubMed.29302757.s7.e0" e2="DDI-PubMed.29302757.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s7.e0" e2="DDI-PubMed.29302757.s7.e1" /></sentence><sentence text="" /><sentence text="The plasma concentrations and tissue accumulation of lamivudine were markedly elevated in Mate1 (-/-) mice as compared to those in Mate1 (+/+) mice"><entity charOffset="53-63" id="DDI-PubMed.29302757.s9.e0" text="lamivudine" /></sentence><sentence text=" Indinavir significantly increased the pharmacokinetic exposure of lamivudine in mice; however, the effect by indinavir was significantly less pronounced in Mate1 (-/-) mice as compared to Mate1(+/+) mice"><entity charOffset="1-10" id="DDI-PubMed.29302757.s10.e0" text="Indinavir" /><entity charOffset="67-77" id="DDI-PubMed.29302757.s10.e1" text="lamivudine" /><entity charOffset="110-119" id="DDI-PubMed.29302757.s10.e2" text="indinavir" /><pair ddi="false" e1="DDI-PubMed.29302757.s10.e0" e2="DDI-PubMed.29302757.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s10.e0" e2="DDI-PubMed.29302757.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29302757.s10.e0" e2="DDI-PubMed.29302757.s10.e2" /><pair ddi="false" e1="DDI-PubMed.29302757.s10.e1" e2="DDI-PubMed.29302757.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29302757.s10.e1" e2="DDI-PubMed.29302757.s10.e2" /></sentence><sentence text="" /><sentence text="MATE1 played an important role in lamivudine pharmacokinetics"><entity charOffset="34-44" id="DDI-PubMed.29302757.s12.e0" text="lamivudine" /></sentence><sentence text=" Indinavir could cause drug-drug interaction with lamivudine in vivo via inhibition of MATE1 and additional mechanism"><entity charOffset="1-10" id="DDI-PubMed.29302757.s13.e0" text="Indinavir" /><entity charOffset="50-60" id="DDI-PubMed.29302757.s13.e1" text="lamivudine" /><pair ddi="false" e1="DDI-PubMed.29302757.s13.e0" e2="DDI-PubMed.29302757.s13.e0" /><pair ddi="false" e1="DDI-PubMed.29302757.s13.e0" e2="DDI-PubMed.29302757.s13.e1" /></sentence><sentence text="" /></document>